Galectin-3: a novel biomarker for the prognosis of heart failure.

about

Galectin-3: a novel biomarker for the prognosis of heart failure.

Item

http://www.wikidata.org/entity/Q36385583

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Galectin-3: a novel biomarker for the prognosis of heart failure.

@ast

Galectin-3: a novel biomarker for the prognosis of heart failure.

@en

type

Item

label

Galectin-3: a novel biomarker for the prognosis of heart failure.

@ast

Galectin-3: a novel biomarker for the prognosis of heart failure.

@en

prefLabel

Galectin-3: a novel biomarker for the prognosis of heart failure.

@ast

Galectin-3: a novel biomarker for the prognosis of heart failure.

@en

P1476

Galectin-3: a novel biomarker for the prognosis of heart failure.

@en

P2093

Hilman Zulkifli Amin

http://www.w3.org/2001/XMLSchema#string

Ika Prasetya Wijaya

http://www.w3.org/2001/XMLSchema#string

Lukman Zulkifli Amin

http://www.w3.org/2001/XMLSchema#string

P2860

Tolvaptan: A Novel Diuretic in Heart Failure Management

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.

Galectin-3: an open-ended story.

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.

Galectin-3: a novel mediator of heart failure development and progression.

Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis.

Critical role of galectin-3 in phagocytosis by macrophages.

Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets.

P304

129-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15386/CJMED-751

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28559694

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5433562

http://www.w3.org/2001/XMLSchema#string